B. Roy

发表

Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells.

J. Bouchard, J. Tremblay, F. Dugré, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

Dystrophin Expression in Muscles of Duchenne Muscular Dystrophy Patients After High-Density Injections of Normal Myogenic Cells

J. Bouchard, J. Tremblay, F. Dugré, 2006, Journal of neuropathology and experimental neurology.

Prevention by anti-LFA-1 of acute myoblast death following transplantation.

C. Huard, D. Skuk, B. Roy, 1997, Journal of immunology.

Myoblast transplantation in non-dystrophic dog

J. Tremblay, M. Fardeau, F. Dugré, 1998, Neuromuscular Disorders.

FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer.

C. Gravel, R. Roy, I. Kinoshita, 1995, Human gene therapy.

Efficacy of Myoblast Transplantation in Nonhuman Primates Following Simple Intramuscular Cell Injections: Toward Defining Strategies Applicable to Humans

D. Skuk, B. Roy, M. Goulet, 2002, Experimental Neurology.

Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigene.

D. Skuk, B. Roy, M. Goulet, 1998, Biochemical and biophysical research communications.

Dynamics of the Early Immune Cellular Reactions after Myogenic Cell Transplantation

D. Skuk, B. Roy, M. Goulet, 2002, Cell transplantation.

First test of a “high-density injection” protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up

J. Bouchard, J. Hogrel, C. Côté, 2007, Neuromuscular Disorders.

Systemic production of human granulocyte colony-stimulating factor in nonhuman primates by transplantation of genetically modified myoblasts.

A. Miller, D. Koeberl, D. Skuk, 2000, Human gene therapy.

Successful Myoblast Transplantation in Primates Depends on Appropriate Cell Delivery and Induction of Regeneration in the Host Muscle

D. Skuk, B. Roy, M. Goulet, 1999, Experimental Neurology.

Resetting the Problem of Cell Death Following Muscle‐Derived Cell Transplantation: Detection, Dynamics and Mechanisms

D. Skuk, B. Roy, M. Goulet, 2003, Journal of neuropathology and experimental neurology.

Partial Laminin ct2 Chain Restoration in ct2 Chain-deficient dy/dy Mouse by Primary Muscle Cell Culture Transplantation

E. Engvall, M. Fardeau, B. Roy, 2002 .

Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation

E. Engvall, M. Fardeau, F. Tomé, 1996, The Journal of cell biology.

Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice

J. Tremblay, B. Roy, M. Goulet, 2002, Neuromuscular Disorders.

Successful myoblast transplantation in fibrotic muscles: no increased impairment by the connective tissue.

B. Roy, M. Goulet, A. Sébille, 1999, Transplantation.

Myoblast Transplantation in Whole Muscle of Nonhuman Primates

D. Skuk, B. Roy, M. Goulet, 2000, Journal of neuropathology and experimental neurology.

Rapid selection of donor myoblast clones for muscular dystrophy therapy using cell surface expression of NCAM.

J. Bouchard, B. Roy, M. Goulet, 1993, European journal of histochemistry : EJH.

Transplantation of human myoblasts in SCID mice as a potential muscular model for myotonic dystrophy.

J. Bouchard, J. Puymirat, D. Furling, 1999, Journal of neuropathology and experimental neurology.

Human myoblast transplantation: A simple assay for tumorigenicity

B. Roy, M. Goulet, J. Tremblay, 1991, Neuromuscular Disorders.

Myoblast Transplantation in Monkeys: Control of Immune Response by FK506

C. Gravel, F. Dugré, B. Roy, 1996, Journal of neuropathology and experimental neurology.